| Literature DB >> 28661269 |
Jie Li1, Qiankun Zhang1, Bofeng Su2.
Abstract
Objective Infection is a common condition in patients with nephrotic syndrome. The objective of the present study is to investigate the clinical characteristics and risk factors of infections in adult patients with primary nephrotic syndrome (PNS). Methods Medical charts of 138 consecutive patients with PNS and infections who were admitted to hospital from April 2013 to April 2016 were systematically reviewed. Results Patients were divided into three groups according to the degree of infections: mild infection group (n = 45), moderate infection group (n = 60), and severe infection group (n = 33). In the severe infection group, most patients (96.9%) had pulmonary infections with opportunistic pathogens. There were significant differences in cumulative prednisone dose, immunosuppressor use, and CD4+ T cell count among the three groups. A lower CD4+ T cell count (<300 cells/mm3) (odds ratio = 4.25 [95% confidence interval 1.680-10.98]) and higher cumulative dose of prednisone (odds ratio = 1.38 [95% confidence interval 1.05-3.26]) were risk factors for severe infections in adult patients with PNS. Conclusions CD4+ T cell count (<300 cells/mm3) and a higher cumulative dose of prednisone are important risk factors for severe infections in adult patients with PNS.Entities:
Keywords: CD4+ T cell; Infection; adult patients; immunosuppression; kidney disease; primary nephrotic syndrome; transplantation
Mesh:
Year: 2017 PMID: 28661269 PMCID: PMC5805218 DOI: 10.1177/0300060517715339
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Sites of infections in patients with PNS (n, %).
| Infection sites | Mild infection (n = 45) | Moderate infection (n = 60) | Severe infection (n = 33) | Total (n = 138) |
|---|---|---|---|---|
| Pulmonary | 23 (51.1) | 45 (75.0) | 32 (96.9) | 100 (72.4) |
| Upper respiratory tract | 17 (37.7) | 0 (0) | 0 (0) | 17 (12.3) |
| Urinary tract | 1 (2.2) | 8 (13.3) | 0 (0) | 9 (6.5) |
| Soft tissue | 2 (4.4) | 3 (5.0) | 0 (0) | 5 (3.6) |
| Gastrointestinal tract | 1 (2.2) | 2 (3.3) | 0 (0) | 3 (2.1) |
| CNS | 0 (0) | 1 (1.6) | 1 (3.0) | 2 (1.4) |
| Others | 1 (2.2) | 1 (1.6) | 0 (0) | 2 (1.4) |
PNS: primary nephrotic syndrome, CNS: central nervous system.
Aetiology of infections in patients with PNS (n, %).
| Aetiology | Mild infection (n = 45) | Moderate infection (n = 60) | Severe infection (n = 33) | Total (n = 138) |
|---|---|---|---|---|
|
| 7 (15.5) | 9 (15.0) | 1 (3.0) | 17 (12.3) |
| Gram-negative bacillus | 5 (11.1) | 4 (6.6) | 0 (0) | 9 (6.5) |
|
| 0 (0) | 6 (10.0) | 3 (9.0) | 9 (6.5) |
|
| 0 (0) | 0 (0) | 8 (24.2) | 8 (5.7) |
|
| 3 (6.6) | 5 (8.3) | 0 (0) | 8 (5.7) |
|
| 4 (8.8) | 4 (6.6) | 0 (0) | 8 (5.7) |
| Nocardiosis | 0 (0) | 0 (0) | 6 (18.1) | 6 (4.3) |
|
| 2 (4.4) | 3 (5.0) | 0 (0) | 5 (3.6) |
|
| 0 (0) | 0 (0) | 3 (9.0) | 3 (2.1) |
|
| 1 (2.2) | 2 (3.3) | 0 (0) | 3 (2.1) |
|
| 0 (0) | 2 (3.3) | 0 (0) | 2 (1.4) |
| Cryptococcus | 0 (0) | 1 (1.6) | 1 (3.0) | 2 (1.4) |
| Others | 1 (2.2) | 6 (10.0) | 0 (0) | 7 (5.0) |
| No isolate | 22 (48.8) | 18 (30.0) | 11 (33.3) | 51 (36.9) |
PNS: primary nephrotic syndrome.
Clinical characteristics of infections in patients with PNS.
| Variables | Mild infection (n = 45) | Moderate infection (n = 60) | Severe infection (n = 33) | Total (n = 138) | |
|---|---|---|---|---|---|
| Sex (female:male) | 18:27 | 24:36 | 9:24 | 51:87 | 0.748 |
| Age (years) | 55.0 ± 15.3 | 60.5 ± 14.8 | 63.0 ± 14.2 | 59.3 ± 14.8 | 0.364 |
| PNS duration (months) | 9.7 ± 15.3 | 10.5 ± 18.7 | 11.2 ± 12.7 | 10.4 ± 16.4 | 0.347 |
| Cumulative dose of prednisone (g) | 1.5 ± 3.5 | 2.9 ± 4.3 | 7.1 ± 6.1 | 3.5 ± 5.0 | 0.013 |
| [ | 6 (13.3) | 21 (35.0) | 21 (63.6) | 48 (34.7) | 0.029 |
| Histological subtype | 0.443 | ||||
| MN | 23 (51.1) | 29 (48.3) | 13 (39.3) | 65 (47.1) | |
| MCD | 14 (31.1) | 22 (36.6) | 11 (33.3) | 47 (34.0) | |
| IgA nephropathy | 6 (13.3) | 3 (5.0) | 5 (15.1) | 14 (10.1) | |
| FSGS | 2 (4.4) | 6 (10.0) | 3 (9.0) | 11 (7.9) | |
| MPGN | 0 (0) | 0 (0) | 1 (3.0) | 1 (0.7) | |
| 24-h urine protein (g/day) | 6.4 ± 2.9 | 6.8 ± 6.6 | 3.6 ± 3.6 | 5.9 ± 5.1 | 0.225 |
| Albumin (g/L) | 19.1 ± 3.7 | 19.3 ± 5.7 | 23.6 ± 6.6 | 20.3 ± 5.6 | 0.076 |
| Scr (µmol/L) | 135.0 ± 41.6 | 165.4 ± 131.5 | 166.2 ± 152.3 | 142.1 ± 138.4 | 0.292 |
| IgG (g/L) | 7.7 ± 3.6 | 5.9 ± 2.4 | 8.4 ± 5.2 | 7.1 ± 3.7 | 0.155 |
| Cholesterol (mmol/L) | 8.1 ± 2.6 | 7.4 ± 3.1 | 5.2 ± 1.5 | 7.1 ± 3.0 | 0.023 |
| CD4 + cell count (cells/mm3) | 533.4 ± 204.5 | 411.4 ± 200.7 | 296.7 ± 185.7 | 436.6 ± 213.6 | 0.017 |
| [ | 3 (6.6) | 18 (30.0) | 9 (27.2) | 30 (21.7) | 0.223 |
| [ | 5 (11.1) | 9 (15.0) | 5 (15.1) | 19 (13.7) | 0.820 |
| Mortality (%) | 0 (0) | 0 (0) | 6 (18.1) | 6 (4.3) | <0.001 |
PNS: primary nephrotic syndrome; MN: membranous nephropathy;
MCD: minimal change disease; FSGS: focal segmental glomerulosclerosis; MPGN: mesangioproliferative glomerulonephritis; Scr: serum creatinine;
IgG: immunoglobulin G.
Including cyclophosphamide, mycophenolate mofetil, cyclosporine A, tacrolimus, and azathioprine.
Including diabetes mellitus, chronic pulmonary disease (chronic obstructive pulmonary disease), and bronchiectasis.
Including sulfamethoxazole and other antibiotics.
Data are shown as mean ± SD (standard deviation) or percentages.
p < 0.05.